Cross-sectional study identifies predominant lineages of Mycobacterium tuberculosis, highlighting rifampicin resistance trends.
BACKGROUND Ethiopia has reported a high rate of extrapulmonary TB (EPTB). We aimed to identify the epidemiology of TB (sub-) lineages and the transmission cluster of EPTB as understanding the driving genotypes helps to implement appropriate intervention. METHODS In a cross-sectional study conducted between 2022–2023, whole genome sequencing was employed on microbiologically confirmed EPTB isolates. A bioinformatics pipeline MTBSeq was used to analyze genomic data. RESULTS The majority (98.1%) of study isolates belonged to the Mycobacterium tuberculosis (MTB) species, and the remaining 1.9% were identified as Mycobacterium bovis . The MTB species were further classified into 4 common lineages and 15 sub-lineages. The Euro-American lineage 4 (63.8%) and East African Indian lineage 3 (31.9%) were predominant. Lineage 4 was further branched into 11 sub-lineages, of which the group Clade1 (n = 78, 48.8%) was the highest, followed by the Haarlem branch (n = 19, 11.9%). The clustering rate and recent transmission index were 12.5% and 6.9% respectively. The risk of rifampicin resistance increases among (sub-)lineage 4.2.2 genotypes. CONCLUSION There was high genotype variability and low clustering rate among main MTBC genotypes and (sub-)lineages of EPTB. M.bovis was detected among EPTB patients in central urban areas.
No takes yet. Share an insight, caveat, or question.
Mollalign et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: